Package 72865-283-05

{"route": ["ORAL"], "spl_id": "1d5c79a3-4eec-f65b-e063-6294a90aab4f", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0372865284018", "0372865285015", "0372865283011"], "unii": ["VZI5B1W380"], "rxcui": ["312136", "312137", "312138"], "spl_set_id": ["9f5d17e4-ca68-48e2-9e87-d3ab1c59aa93"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["XLCare Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (72865-283-01)", "package_ndc": "72865-283-01", "marketing_start_date": "20240718"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (72865-283-05)", "package_ndc": "72865-283-05", "marketing_start_date": "20240718"}], "brand_name": "Oxcarbazepine", "product_id": "72865-283_1d5c79a3-4eec-f65b-e063-6294a90aab4f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72865-283", "generic_name": "Oxcarbazepine", "labeler_name": "XLCare Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxcarbazepine", "active_ingredients": [{"name": "OXCARBAZEPINE", "strength": "150 mg/1"}], "application_number": "ANDA215939", "marketing_category": "ANDA", "marketing_start_date": "20240718", "listing_expiration_date": "20261231"}